Abstract
The European Union Nitric Oxide trial was designed to assess the potential benefits of inhaled nitric oxide (iNO) compared with placebo in infants with respiratory failure. This follow-up study evaluated respiratory, neurodevelopmental, and other outcomes for infants entered into the European Union Nitric Oxide trial to age 2 years.
| Original language | English |
|---|---|
| Pages (from-to) | e695-e703 |
| Journal | Pediatrics |
| Volume | 132 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Administration, Inhalation
- Bronchodilator Agents
- Child, Preschool
- European Union
- Female
- Follow-Up Studies
- Humans
- Infant
- Infant, Newborn
- Male
- Nitric Oxide
- Respiratory Distress Syndrome, Newborn
- Survival Rate
- developmental outcomes
- growth
- inhaled nitric oxide
- premature infants
- randomized controlled trial
Fingerprint
Dive into the research topics of 'Two-year outcomes of a randomized controlled trial of inhaled nitric oxide in premature infants'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver